Press Releases

Are you attending the 64th American Society of Hematology (ASH) Annual Meeting in New Orleans this weekend? Come visit Oncology Data Advisor and ConveyMED while you are there! We will be attending and conducting live interviews discussing the latest research, news, and updates from the conference. Visit us in the press area outside of rooms 256-257 from 9:00 AM to 5:00 PM on December 10, 11, and 12 to record a podcast, share your research and experiences at ASH, and network with fellow attendees. Contact Keira Smith at This email address is being protected from spambots. You need JavaScript enabled to view it. to schedule a time to meet with us and discuss your research and knowledge in a podcast which will be shared with our audience of health care professionals, or simply stop by at your convenience. Just look for the Oncology Data Advisor sign! Thank you for helping Oncology Data Advisor and ConveyMED in our goal of making the abundance of valuable information being presented this weekend accessible to everyone! ...
i3 Health is honored to be recognized as a 2022 recipient of the Nursing Continuing Professional Development (NCPD) Premier Award presented by the American Nurses Credentialing Center (ANCC) NCPD Accreditation Program. Awarded annually, the NCPD Premier Award is presented to accredited providers that excel in developing high-quality NCPD-accredited educational activities. Recipients of this prestigious award are exemplary organizations that serve as role models in the field of nursing education. i3 Health was awarded this recognition for exemplifying a culture of empowerment that engages nurses in shared decision making and interprofessional collaboration, and for sustaining a culture of evidence-based education in alignment with public health initiatives and its own strategic goals. "i3 Health is honored and grateful to be recognized as a 2022 recipient of the ANCC NCPD Premier Award," commented Melissa Cutrona, General Manager of i3 Health. "This recognition will aid us in furthering...
Rochelle Park, NJ—October 4, 2022 – i3 Health and Oncology Data Advisor™ are happy to announce ODACon™ 2022 Supportive Care Summit: Managing Toxicities of Novel Breast Cancer Therapies, which will be held on Saturday, November 12, 2022. i3 Health is pleased to partner with the National Breast Cancer Foundation® (NBCF). In honor of Breast Cancer Awareness Month, 20% of the registration fee will be donated to NBCF during October. This one-day virtual conference will feature seven engaging case-based discussions encompassing the topics of emerging data on novel therapy classes, up-to-date management and treatment strategies, and best practices in supportive care for patients with breast cancer. Attendees will be able to earn 5.5 AMA PRA Category 1 Credits™, ANCC contact hours, ACPE contact hours, MOC points, and ILNA points. By attending this year's ODACon, you will learn how to stay up-to-date with the evolving landscape in the breast cancer field in order to gain more confiden...
i3 Health's study focusing on the effectiveness of a nursing continuing professional development (NCPD)–approved activity to improve clinicians' knowledge of the individualized treatment of patients with non-Hodgkin lymphoma (NHL) has been published as a 47th Annual Oncology Nursing Society (ONS) Congress online abstract. The abstract, authored by Elizabeth Heller, PhD; Keira Smith, BA; Kristin Wright, PharmD; and Sarah Williams, MAT, of i3 Health, and Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager at MD Anderson Cancer Center, who also served as chair for this activity, features learning outcomes regarding the latest strategies in nursing management of advanced aggressive NHLs, including diffuse large B-cell lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma. This live NCPD-approved activity occurred online in a 1-hour game show format at the 46th Annual ONS Congress on April 27, 2021. Participants were given an identical pretest and posttest for the goal of as...
ROCHELLE PARK, NJ—January 12, 2022 – i3 Health and Oncology Data Advisor have announced that ODACon, a Rare Hematologic Malignancies Symposium, will be held on January 29, 2022. This 1-day virtual conference features 5 exclusive sessions on emerging data in hematologic malignancies, including acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL), mantle cell lymphoma (MCL), myelodysplastic syndromes (MDS), and Waldenstrom macroglobulinemia (WM), all presented by expert faculty. Attendees can receive up to 5.0 AMA PRA Category 1 CreditsTM for physicians, 5.0 ANCC contact hours for nurses, or 5.0 ACPE contact hours for pharmacists. ODACon is chaired by Amir Fathi, MD, Associate Professor of Medicine at Harvard Medical School and Director of the Center for Leukemia at Massachusetts General Hospital. Dr. Fathi will highlight individualized treatment selection for patients with ALL, as well as the latest efficacy and safety data for novel therapeutic strategies. Louis Diehl, MD, Profess...

Copyright © 2022 Oncology Data Advisor. All rights reserved.